| Artemisinins target GABAA receptor signaling and impair α cell identity J Li, T Casteels, T Frogne, C Ingvorsen, C Honore, M Courtney, ... Cell 168 (1), 86-100. e15, 2017 | 379 | 2017 |
| Nek9 is a Plk1‐activated kinase that controls early centrosome separation through Nek6/7 and Eg5 MT Bertran, S Sdelci, L Regué, J Avruch, C Caelles, J Roig The EMBO journal 30 (13), 2634-2647, 2011 | 208 | 2011 |
| Nek9 phosphorylation of NEDD1/GCP-WD contributes to Plk1 control of γ-tubulin recruitment to the mitotic centrosome S Sdelci, M Schütz, R Pinyol, MT Bertran, L Regué, C Caelles, I Vernos, ... Current Biology 22 (16), 1516-1523, 2012 | 99 | 2012 |
| ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion E Rovida, E Spinelli, S Sdelci, V Barbetti, A Morandi, S Giuntoli, ... The Journal of Immunology 180 (6), 4166-4172, 2008 | 76 | 2008 |
| MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation S Sdelci, AF Rendeiro, P Rathert, W You, JMG Lin, A Ringler, G Hofstätter, ... Nature genetics 51 (6), 990-998, 2019 | 67 | 2019 |
| Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk S Sdelci, CH Lardeau, C Tallant, F Klepsch, B Klaiber, J Bennett, ... Nature Chemical Biology 12 (7), 504-510, 2016 | 48 | 2016 |
| NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation MP Licciardello, MK Müllner, G Dürnberger, C Kerzendorfer, B Boidol, ... Oncogene 34 (29), 3780-3790, 2015 | 48 | 2015 |
| Nek9, Nek6, Nek7 and the separation of centrosomes S Sdelci, MT Bertran, J Roig Cell cycle 10 (22), 3816-3817, 2011 | 44 | 2011 |
| DYNLL/LC8 protein controls signal transduction through the Nek9/Nek6 signaling module by regulating Nek6 binding to Nek9 L Regué, S Sdelci, MT Bertran, C Caelles, D Reverter, J Roig Journal of Biological Chemistry 286 (20), 18118-18129, 2011 | 42 | 2011 |
| A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor MP Licciardello, A Ringler, P Markt, F Klepsch, CH Lardeau, S Sdelci, ... Nature chemical biology 13 (7), 771-778, 2017 | 41 | 2017 |
| Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTEN C Cellai, A Laurenzana, E Bianchi, S Sdelci, R Manfredini, AM Vannucchi, ... Experimental Hematology 37 (10), 1176-1185. e21, 2009 | 28 | 2009 |
| Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin states KC Li, E Girardi, F Kartnig, S Grosche, T Pemovska, JW Bigenzahn, ... Nature metabolism 3 (5), 651-664, 2021 | 9 | 2021 |
| Metabolic modulation of transcription: the role of one-carbon metabolism JMG Lin, S Kourtis, R Ghose, NP Lorente, S Kubicek, S Sdelci Cell Chemical Biology 29 (12), 1664-1679, 2022 | 8 | 2022 |
| A metabolic map of the DNA damage response identifies PRDX1 in the control of nuclear ROS scavenging and aspartate availability A Moretton, S Kourtis, A Gañez Zapater, C Calabrò, ML Espinar Calvo, ... Molecular Systems Biology 19 (7), e11267, 2023 | 4 | 2023 |
| A metabolic map of the DNA damage response identifies PRDX1 in nuclear ROS scavenging and aspartate synthesis A Moretton, S Kourtis, C Calabrò, AG Zapater, F Fontaine, AC Müller, ... bioRxiv, 2022.08. 01.500855, 2022 | 4* | 2022 |
| Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer L Pascual‐Reguant, Q Serra‐Camprubí, D Datta, D Cianferoni, S Kourtis, ... EMBO Molecular Medicine 15 (12), e18459, 2023 | 1 | 2023 |
| Nuclear MTHFD2 secures mitosis progression by preserving centromere integrity N Pardo-Lorente, A Gkanogiannis, L Cozzuto, A Ganez Zapater, ... bioRxiv, 2023.06. 01.543193, 2023 | 1 | 2023 |
| TAF1 inhibitors for the therapy of cancer S Sdelci, S Kubicek US Patent 10,702,518, 2020 | 1 | 2020 |
| Taf1 inhibitors for the therapy of cancer S SDELCI, S Kubicek | 1 | 2017 |
| MTHFD2 in healthy and cancer cells: Canonical and non-canonical functions N Pardo-Lorente, S Sdelci npj Metabolic Health and Disease 2 (1), 3, 2024 | | 2024 |
